National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

2-methoxyestradiol
An orally bioavailable estradiol metabolite with potential antineoplastic activity. 2-Methoxyestradiol inhibits angiogenesis by reducing endothelial cell proliferation and inducing endothelial cell apoptosis. This agent also inhibits tumor cell growth by binding to tubulin, resulting in antimitotic activity, and by inducing caspase activation, resulting in cell cycle arrest in the G2 phase, DNA fragmentation, and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:2-ME
2-Methoxy Estradiol
US brand name:Panzem
Abbreviation:2ME2
Chemical structure name:(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol



Previous:123-I-MIP-1095, 131I-TM-601, 18F-FHBG, 18F-fluoromethylcholine, 18F-fluoromisonidazole
Next:3'-deoxy-3'-[18F]fluorothymidine, 3,4-methylenedioxymethamphetamine, 3-deazauridine, 4'-iodo-4'-deoxydoxorubicin, 4-hydroxytamoxifen

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov